Boehringer or­ga­nizes a coali­tion in search of first CF gene ther­a­py, work­ing with re­search, man­u­fac­tur­ing part­ners

Join­ing hands with sev­er­al aca­d­e­m­ic and in­dus­try part­ners from the UK, Boehringer In­gel­heim is launch­ing a quest to de­vel­op a gene ther­a­py for cys­tic fi­bro­sis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER